Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroblast Activation Protein Inhibitor”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Looking for participantsNCT06355427
What this trial is testing

The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Mara Veenstra, MD 81
Not applicableLooking for participantsNCT06277180
What this trial is testing

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

Who this might be right for
Medullary Thyroid CancerPrositron Emission TomographyFibroblast Activation Protein Inhibitor+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Early research (Phase 1)Looking for participantsNCT05172310
What this trial is testing

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Who this might be right for
Pancreatic NeoplasmsStomach NeoplasmsBile Duct Neoplasms+1 more
Karolinska University Hospital 410
Early research (Phase 1)Study completedNCT06974565
What this trial is testing

Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16
Not applicableLooking for participantsNCT05034146
What this trial is testing

68Ga-FAPI PET/CT in Malignant Tumors

Who this might be right for
Fibroblast Activation Protein InhibitorPET/CTMalignant Neoplasm
Zhongnan Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT06659705
What this trial is testing

Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Institut Curie 35
Testing effectiveness (Phase 2)Study completedNCT05898854
What this trial is testing

[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer

Who this might be right for
Gastric CancerGastro Esophageal Junctional CancerCancer
Aalborg University Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT07217717
What this trial is testing

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
SOFIE 200
Very early researchLooking for participantsNCT07132645
What this trial is testing

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumor
University of Michigan Rogel Cancer Center 30
Not applicableStudy completedNCT07139054
What this trial is testing

68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Cancer
The First Affiliated Hospital of Xiamen University 31
Testing effectiveness (Phase 2)Looking for participantsNCT07083011
What this trial is testing

68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Mayo Clinic 35
Not applicableLooking for participantsNCT06107608
What this trial is testing

Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors

Who this might be right for
Non Small Cell Lung Cancer
Jules Bordet Institute 58
Early research (Phase 1)Study completedNCT06846528
What this trial is testing

Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 16
Not applicableLooking for participantsNCT07337850
What this trial is testing

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

Who this might be right for
Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)
Tata Memorial Centre 60
Not applicableLooking for participantsNCT06061874
What this trial is testing

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis

Who this might be right for
CancerPeritoneal Carcinomatosis
Jules Bordet Institute 80
Not applicableLooking for participantsNCT06792318
What this trial is testing

The Role of FAPI PET-CT in Diagnosing Endometriosis

Who this might be right for
Endometriosis
Ziv Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT07217704
What this trial is testing

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Who this might be right for
Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction
SOFIE 200
Not applicableUnknownNCT05845151
What this trial is testing

Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06503146
What this trial is testing

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Who this might be right for
SarcomaSmall Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma+7 more
National Cancer Institute (NCI) 320
Testing effectiveness (Phase 2)Looking for participantsNCT05903807
What this trial is testing

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Aalborg University Hospital 50
Load More Results